Cunningham: 2015 Could Be A Big Year For Ophthalmology

[creativ_pullleft colour=”light-gray” colour_custom=”” text=”Episode 020″]

OIS Co-Chair Emmett Cunningham delivers a high altitude review of the much sought after “Year in Review” report he delivers at each event. In this review, Cunningham touched upon his hopes for the sector & OIS.

Podcast Guest

Emmett Cunningham

Emmett T. Cunningham Jr., MD, PhD, MPH

Dr. Cunningham joined Clarus Ventures with 20+ years in the biomedical and biopharmaceutical sectors. Prior, Dr. Cunningham was the SVP, Medical Strategy at Eyetech Pharmaceuticals. He helped build and lead the team that developed and commercialized Macugen.

View Full Profile